Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Phase 1 symbols : EBS save search
Emergent BioSolutions Initiates Phase 1 Study Evaluating Lassa Virus Vaccine Candidate
Published: 2022-09-06 (Crawled : 11:00) - biospace.com/
EBS | News | $2.29 6.02% 0.0% 860K
|
Health Technology
|
| O: -0.48%
H: 0.0%
C: -2.58%
candidate vaccine virus study phase 1
Emergent BioSolutions Initiates Phase 1 Study Evaluating Potential Intranasal Treatment for Cyanide Poisoning
Published: 2022-03-11 (Crawled : 12:00) - globenewswire.com
EBS | News | $2.29 6.02% 0.0% 860K
|
Health Technology
|
| O: -5.51%
H: 0.0%
C: 0.0%
treatment solutions phase 1 potential merge phase 2 phase 3
Emergent BioSolutions Announces Initiation of Phase 1 Study Evaluating Its Universal Influenza Vaccine Candidate
Published: 2021-12-16 (Crawled : 13:30) - biospace.com/
EBS | News | $2.29 6.02% 0.0% 860K
|
Health Technology
|
| O: 3.55%
H: 2.32%
C: 0.54%
phase 1 vaccine influenza merge phase 2 phase 3
Gainers vs Losers
| 78% | 22% |
Top 10 Gainers
MTTR | News M | $4.6 164.37% 62.17% 28M
|
AGBA | $2.94 135.2% 57.48% 66M
|
Finance
EDBL | News | $6.46 71.81% 41.8% 2M
|
MTC | $2.25 44.23% 30.67% 6M
|
Technology Services
OPRT | News | $3.175 41.11% 29.13% 12M
|
Finance
SHIM | $3.05 35.56% 26.23% 1.1M
|
HKIT | $1.345 31.86% 24.16% 390K
|
Technology Services
ABVC | $1.36 30.77% 23.53% 7.4M
|
Wholesale Trade
OST | $0.512 28.0% 21.88% 290K
|
POET | $1.59 27.2% 21.38% 4.2M
|
Manufacturing
Your saved searches
Save your searches and get alerts when important news are released.